Clinical Trial Update: Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer [Phase 2]

View source ↗

Summary

The Phase 2 trial of oxaliplatin, capecitabine, and bevacizumab followed by surgery and/or radiofrequency ablation in colorectal cancer patients has been withdr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: University of California, Davis | Conditions: Colorectal Cancer, Metastatic Cancer | Phase 2 | Status: WITHDRAWN